U.S. Markets closed

Recro Pharma, Inc. (REPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.53+0.03 (+0.35%)
At close: 4:00PM EDT

8.53 0.00 (0.00%)
After hours: 4:08PM EDT

People also watch
Interactive chart
Previous Close8.50
Bid6.75 x 1000
Ask8.75 x 1000
Day's Range8.39 - 8.57
52 Week Range5.89 - 12.50
Avg. Volume155,624
Market Cap162.51M
PE Ratio (TTM)-3.54
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press12 days ago

    Recro Pharma reports 1Q loss

    On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 42 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • Capital Cube2 months ago

    ETFs with exposure to Recro Pharma, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Recro Pharma, Inc. Here are 5 ETFs with the largest exposure to REPH-US. Comparing the performance and risk of Recro Pharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Recro Pharma, Inc. :REPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube2 months ago

    Recro Pharma, Inc. :REPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Recro Pharma, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Recro Pharma, Inc. – Galena Biopharma, Inc., Johnson & Johnson, Depomed, Inc., Flexion Therapeutics, Inc., Pacira Pharmaceuticals, Inc., Cara Therapeutics Inc, AcelRx Pharmaceuticals, Inc. and DURECT Corporation (GALE-US, ... Read more (Read more...)